Michael D. Pak

Array ( [id] => 6374645 [patent_doc_number] => 20100081163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'ION CHANNEL ASSAY METHODS' [patent_app_type] => utility [patent_app_number] => 12/568604 [patent_app_country] => US [patent_app_date] => 2009-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 46727 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20100081163.pdf [firstpage_image] =>[orig_patent_app_number] => 12568604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685247 [patent_doc_number] => 20100120894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'Intracellular DNA receptor' [patent_app_type] => utility [patent_app_number] => 12/586662 [patent_app_country] => US [patent_app_date] => 2009-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 18838 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120894.pdf [firstpage_image] =>[orig_patent_app_number] => 12586662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8227280 [patent_doc_number] => 20120141488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'NOVEL G PROTEIN COUPLED RECEPTOR PROTEIN AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/322304 [patent_app_country] => US [patent_app_date] => 2009-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15189 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13322304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6607794 [patent_doc_number] => 20100063260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'Whitefly Ecdysone Receptor Antibody' [patent_app_type] => utility [patent_app_number] => 12/553560 [patent_app_country] => US [patent_app_date] => 2009-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 30711 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20100063260.pdf [firstpage_image] =>[orig_patent_app_number] => 12553560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7754459 [patent_doc_number] => 20120027683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'DIABETES T CELL RECEPTORS' [patent_app_type] => utility [patent_app_number] => 13/060230 [patent_app_country] => US [patent_app_date] => 2009-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 12036 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027683.pdf [firstpage_image] =>[orig_patent_app_number] => 13060230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6024235 [patent_doc_number] => 20110052561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'OSTEOLYSIS TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/549116 [patent_app_country] => US [patent_app_date] => 2009-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7699 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052561.pdf [firstpage_image] =>[orig_patent_app_number] => 12549116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10051808 [patent_doc_number] => 09091678 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-28 [patent_title] => 'Method for identifying compounds useful for treating and/or preventing disease-associated bone loss' [patent_app_type] => utility [patent_app_number] => 13/059446 [patent_app_country] => US [patent_app_date] => 2009-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 10883 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13059446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5944045 [patent_doc_number] => 20110104665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'MUTANT SODIUM CHANNEL NAV 1.7 AND METHODS RELATED THERETO' [patent_app_type] => utility [patent_app_number] => 12/536245 [patent_app_country] => US [patent_app_date] => 2009-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 25539 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104665.pdf [firstpage_image] =>[orig_patent_app_number] => 12536245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6548967 [patent_doc_number] => 20100222410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'Nuclease compositions and methods' [patent_app_type] => utility [patent_app_number] => 12/460446 [patent_app_country] => US [patent_app_date] => 2009-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 30197 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20100222410.pdf [firstpage_image] =>[orig_patent_app_number] => 12460446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7488628 [patent_doc_number] => 20110236907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'RADIOLABLED CYCLOPAMINE ASSAY FOR THE SMOOTHENED RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/999922 [patent_app_country] => US [patent_app_date] => 2009-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3545 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236907.pdf [firstpage_image] =>[orig_patent_app_number] => 12999922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5464977 [patent_doc_number] => 20090325177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'Sensitive And Rapid Methods Of Using Chimeric Receptors To Identify Autoimmune Disease And Assess Disease Severity' [patent_app_type] => utility [patent_app_number] => 12/483689 [patent_app_country] => US [patent_app_date] => 2009-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 25293 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0325/20090325177.pdf [firstpage_image] =>[orig_patent_app_number] => 12483689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374675 [patent_doc_number] => 20090312236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'PEGYLATED INSULIN LISPRO COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/481111 [patent_app_country] => US [patent_app_date] => 2009-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19823 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312236.pdf [firstpage_image] =>[orig_patent_app_number] => 12481111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7697105 [patent_doc_number] => 20110229485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'INHIBITION OF THE NT-3:TRKC BOUND AND ITS APPLICATION TO THE TREATMENT OF CANCER SUCH AS NEUROBLASTOMA' [patent_app_type] => utility [patent_app_number] => 12/993663 [patent_app_country] => US [patent_app_date] => 2009-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 18445 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229485.pdf [firstpage_image] =>[orig_patent_app_number] => 12993663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6201869 [patent_doc_number] => 20110064655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'BIOMARKERS FOR DEPRESSION' [patent_app_type] => utility [patent_app_number] => 12/991916 [patent_app_country] => US [patent_app_date] => 2009-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13894 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20110064655.pdf [firstpage_image] =>[orig_patent_app_number] => 12991916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8200372 [patent_doc_number] => 08187821 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-29 [patent_title] => 'Compositions and methods for the modulation of PGRMC1' [patent_app_type] => utility [patent_app_number] => 12/436316 [patent_app_country] => US [patent_app_date] => 2009-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13559 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 222 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/187/08187821.pdf [firstpage_image] =>[orig_patent_app_number] => 12436316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7566968 [patent_doc_number] => 20110287031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'Covalently reactive transition state analogs and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/387020 [patent_app_country] => US [patent_app_date] => 2009-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 22333 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20110287031.pdf [firstpage_image] =>[orig_patent_app_number] => 12387020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10110830 [patent_doc_number] => 09146238 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-29 [patent_title] => 'Compositions and methods for treating or preventing prostate cancer and for detecting androgen receptor variants' [patent_app_type] => utility [patent_app_number] => 12/988299 [patent_app_country] => US [patent_app_date] => 2009-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 43 [patent_no_of_words] => 27954 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12988299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8138579 [patent_doc_number] => 20120093837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'COMPOSITIONS AND METHODS FOR DETECTING EGFR IN CANCER' [patent_app_type] => utility [patent_app_number] => 12/450457 [patent_app_country] => US [patent_app_date] => 2009-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 33759 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20120093837.pdf [firstpage_image] =>[orig_patent_app_number] => 12450457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6021920 [patent_doc_number] => 20110050246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'Method for Screening Olfactory Sensibility Inhibitor' [patent_app_type] => utility [patent_app_number] => 12/936978 [patent_app_country] => US [patent_app_date] => 2009-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4041 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20110050246.pdf [firstpage_image] =>[orig_patent_app_number] => 12936978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7966163 [patent_doc_number] => 07939494 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-10 [patent_title] => 'Method for administering GLP-1 molecules' [patent_app_type] => utility [patent_app_number] => 12/421590 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14754 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/939/07939494.pdf [firstpage_image] =>[orig_patent_app_number] => 12421590 [rel_patent_id] =>[rel_patent_doc_number] =>)